Adicet Bio Inc (NASDAQ: ACET) — Healthcare · Share Price, Chart & Market Data
About: Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.88 (-0.25%)
ACETAdicet Bio Inc
Loading watchlist status…
Trade ACET now
Adicet Bio Inc share price
ACET price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:00 am GMT+0
ACET price performance
-2.233%
5D
21.793%
1M
-10.658%
YTD
1,171.173%
1Y
ACET price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:00 am GMT+0
ACET details
ACET Market Signals